PL434216A1 - Pochodne (1S,4S,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu lub 1S,4R,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu oraz sposób ich wytwarzania - Google Patents
Pochodne (1S,4S,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu lub 1S,4R,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu oraz sposób ich wytwarzaniaInfo
- Publication number
- PL434216A1 PL434216A1 PL434216A PL43421620A PL434216A1 PL 434216 A1 PL434216 A1 PL 434216A1 PL 434216 A PL434216 A PL 434216A PL 43421620 A PL43421620 A PL 43421620A PL 434216 A1 PL434216 A1 PL 434216A1
- Authority
- PL
- Poland
- Prior art keywords
- azabicyclo
- triazol
- phenylethyl
- octane
- derivatives
- Prior art date
Links
- HTUGQRZJLWWLSC-PQEBFOHHSA-N C[C@@H](C1=CC=CC=C1)N(C1)[C@@H](CC2)C[C@@H]2[C@@H]1N1N=NC=C1 Chemical compound C[C@@H](C1=CC=CC=C1)N(C1)[C@@H](CC2)C[C@@H]2[C@@H]1N1N=NC=C1 HTUGQRZJLWWLSC-PQEBFOHHSA-N 0.000 title abstract 2
- HTUGQRZJLWWLSC-ORQFMDKSSA-N (1S,4R,5R)-2-[(1S)-1-phenylethyl]-4-(triazol-1-yl)-2-azabicyclo[3.2.1]octane Chemical compound C1(=CC=CC=C1)[C@H](C)N1[C@H]2CC[C@@H]([C@H](C1)N1N=NC=C1)C2 HTUGQRZJLWWLSC-ORQFMDKSSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem wynalazku są pochodne (1S,4S,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu lub (1S,4R,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu, oraz sposób ich wytwarzania. Pochodne te przeznaczone są do stosowania w medycynie jako środki zwalczające komórki rakowe.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL434216A PL241225B1 (pl) | 2020-06-05 | 2020-06-05 | Pochodne (1S,4S,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1- -ylo)-2-azabicyklo[3.2.1]oktanu lub 1S,4R,5R)-2-((S)-1-fenyloetylo)- -4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu oraz sposób ich wytwarzania |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL434216A PL241225B1 (pl) | 2020-06-05 | 2020-06-05 | Pochodne (1S,4S,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1- -ylo)-2-azabicyklo[3.2.1]oktanu lub 1S,4R,5R)-2-((S)-1-fenyloetylo)- -4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu oraz sposób ich wytwarzania |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL434216A1 true PL434216A1 (pl) | 2021-12-06 |
| PL241225B1 PL241225B1 (pl) | 2022-08-22 |
Family
ID=80002107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL434216A PL241225B1 (pl) | 2020-06-05 | 2020-06-05 | Pochodne (1S,4S,5R)-2-((S)-1-fenyloetylo)-4-(1H-1,2,3-triazol-1- -ylo)-2-azabicyklo[3.2.1]oktanu lub 1S,4R,5R)-2-((S)-1-fenyloetylo)- -4-(1H-1,2,3-triazol-1-ylo)-2-azabicyklo[3.2.1]oktanu oraz sposób ich wytwarzania |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL241225B1 (pl) |
-
2020
- 2020-06-05 PL PL434216A patent/PL241225B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL241225B1 (pl) | 2022-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2025011774A (es) | Compuestos de imidazolil pirimidinilamina como inhibidores de cdk2 | |
| CR20220537A (es) | [1,3]DIAZINO[5,4-d]PIRIMIDINAS COMO INHIBIDORES DE HER2 | |
| MX2025002487A (es) | Aminas biciclicas como inhibidores de la cinasa dependiente de ciclina 2 (cdk2) | |
| GEAP202415945A (en) | Bicyclic heterocycles as fgfr inhibitors | |
| PE20220750A1 (es) | Imidazopirimidinas como inhibidores de eed y uso de estas | |
| MX2023002792A (es) | Preparacion farmaceutica. | |
| MY206642A (en) | Ophthalmic composition for treatment of dry eye disease | |
| HRP20050967B1 (hr) | Derivati pirazolo-kinazolina, postupak njihovog dobivanja i njihova uporaba kao inhibitora kinaze | |
| MX2024013020A (es) | Compuestos de heteroarilo para el tratamiento del dolor | |
| FR16C0021I2 (fr) | Azetidines en tant qu'inhibiteurs de mek et leur utilisation pour le traitement des maladies proliferatives | |
| TW200514776A (en) | Aminotriazole compounds useful as inhibitors of protein kinases | |
| MA38391A1 (fr) | Dérivés de pyridinyl et triazolone pyridinyl de fusion | |
| MX2023010711A (es) | Fenalquilaminas y métodos de preparación y uso de las mismas. | |
| PH12022551960A1 (en) | Antibodies binding to b7h4 | |
| CR20240514A (es) | Compuestos de heteroarilo para el tratamiento del dolor | |
| WO2019175198A3 (en) | Antibodies | |
| WO2017219029A3 (en) | Compositions and methods for the depletion of cd117+cells | |
| EA202091475A1 (ru) | ПРОИЗВОДНЫЕ 5-(2-(2,5-ДИФТОРФЕНИЛ)ПИРРОЛИДИН-1-ИЛ)-3-(1H-ПИРАЗОЛ-1-ИЛ)ПИРАЗОЛО[1,5-а]ПИРИМИДИНА И РОДСТВЕННЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ Trk КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ РАКА | |
| ZA202203520B (en) | [1,4]oxazepino[2,3-c]quinolinone derivatives as bcl6 inhibitors | |
| IL158116A0 (en) | Inhibitors of cyclin dependent kinases as anti-cancer agent | |
| AU2020288559A8 (en) | Pyrazole and imidazole derivatives, compositions and methods as orexin antagonists | |
| MX2025012347A (es) | Compuestos heterociclicos y usos de estos | |
| PH12019502086A1 (en) | Deuterated imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| WO2019199667A3 (en) | Pladienolide compounds and their use | |
| MX2024004874A (es) | Compuestos heterociclicos para uso en el tratamiento de cancer. |